Bernasko James
North Shore Center for Diabetes in Pregnancy, Division of Maternal-Fetal Medicine, North Shore-Long Island Jewish Health System, North Shore University Hospital, Manhasset, NY 11030, USA.
J Matern Fetal Neonatal Med. 2007 Feb;20(2):125-32. doi: 10.1080/14767050601144727.
The role of intensive insulin therapy (IIT) in the reduction of long-term diabetes-related complications is well established. Normal blood glucose level prior to and during pregnancy is critical in reducing both short- and long-term morbidity and mortality in mother and infant. IIT in pregnancy, though occasionally challenging, is necessary to achieve and maintain normal blood glucose level during pregnancy. Current knowledge and recent advances in insulin formulations and delivery systems have improved our ability to achieve glycemic targets in pregnancy while limiting maternal and fetal morbidity. The objective of this review is to discuss contemporary strategies for successful use of IIT in pregnancy.
强化胰岛素治疗(IIT)在降低长期糖尿病相关并发症方面的作用已得到充分证实。妊娠前及妊娠期间的正常血糖水平对于降低母婴的短期和长期发病率及死亡率至关重要。妊娠期间的强化胰岛素治疗虽然偶尔具有挑战性,但对于在妊娠期间实现并维持正常血糖水平是必要的。胰岛素制剂和给药系统方面的现有知识及最新进展提高了我们在妊娠期间实现血糖目标同时限制母婴发病率的能力。本综述的目的是讨论在妊娠期间成功使用强化胰岛素治疗的当代策略。